Miroi AB has been acquired by Via Venture Partners
The shareholders of Miroi AB, one of the leading e-learning company in adult education, have sold 70% of the company to Via Venture Partners for an undisclosed consideration.
Miroi AB is one of the leading e-learning companies in adult education and job matching. The company operates in around 60 locations in Sweden and has its head office in Luleå.
Via Venture Partners invests in companies ready to expand outside the Nordic region, but it also supports seed and early stage ventures. Although it invest in companies of all sizes, the focus is on those with revenues between US$7– 40 million.
The shareholders have retained 30% of the shares.
Oaklins' team in Sweden advised the seller in this transaction.
Prata med transaktionsteamet
Relaterade transaktioner
Niscon Inc. has been acquired by SGPS ShowRig
Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.
Lär dig merFairfest Media has acquired WTE Miami
Fairfest Media, organizer of OTM, the leading travel show in Asia, has acquired WTE Miami, the fastest-growing travel trade show in the USA. The acquisition marks a significant milestone in Fairfest’s global expansion, strengthening its presence in the Americas and beyond by leveraging decades of experience and leadership in Asia and India.
Lär dig merBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Lär dig mer